☆ 4.7 Letter

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

BRAIN BEHAVIOR AND IMMUNITY (2020)

Journal

BRAIN BEHAVIOR AND IMMUNITY

Volume 87, Issue -, Pages 120-121

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

DOI: 10.1016/j.bbi.2020.04.079

Keywords

SARS-CoV2; Rhesus macaque; Cannabinoids; Inflammation; Cytokine; Lung

Funding

National Institutes of Health [R01DA042524, R01DA050169, R56DE026930, P51OD0111133]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Journal

BRAIN BEHAVIOR AND IMMUNITY

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Journal

BRAIN BEHAVIOR AND IMMUNITY

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper